Associated Papers
Osteogenesis imperfecta: pathogenesis, classification, and treatment.
Hasegawa K
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology, 2025
Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta.
Misof BM et al.
Calcified Tissue International, 2024
Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives.
Xiaohui T et al.
Journal of Orthopaedic Translation, 2024
An Update on Animal Models of Osteogenesis Imperfecta.
Lv F et al.
Calcified Tissue International, 2022
Impact of Genetic and Pharmacologic Inhibition of Myostatin in a Murine Model of Osteogenesis Imperfecta.
Omosule CL et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research, 2021
A Roadmap to Gene Discoveries and Novel Therapies in Monogenic Low and High Bone Mass Disorders.
Formosa MM et al.
Frontiers in Endocrinology, 2021
Osteogenesis Imperfecta: New Perspectives From Clinical and Translational Research.
Tauer JT et al.
Jbmr Plus, 2019
Osteogenesis Imperfecta: Muscle-Bone Interactions when Bi-directionally Compromised.
Phillips CL et al.
Current Osteoporosis Reports, 2018
Application of anti-Sclerostin therapy in non-osteoporosis disease models.
Jacobsen CM
Bone, 2017
Bone mineral properties in growing Col1a2(+/G610C) mice, an animal model of osteogenesis imperfecta.
Masci M et al.
Bone, 2016
Select a paper to view details